Senturk, S. Et Al. 2025. The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.. Journal of clinical medicine , vol.14, no.17 .

Senturk, S., Kagitci, M., Mercantepe, T., Bedir, R., & Kuruca, N., (2025). The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.. Journal of clinical medicine , vol.14, no.17.

Senturk, Senol Et Al. "The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.," Journal of clinical medicine , vol.14, no.17, 2025

Senturk, Senol Et Al. "The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.." Journal of clinical medicine , vol.14, no.17, 2025

Senturk, S. Et Al. (2025) . "The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.." Journal of clinical medicine , vol.14, no.17.

@article{article, author={Senol Senturk Et Al. }, title={The Role of STAT-3 and IL-26 Signaling Pathways in Leiomyoma Pathophysiology.}, journal={Journal of clinical medicine}, year=2025}